Assertio Therapeutics Inc (USD)
ASRT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.62 | 0.66
52-Wk Range |
Last Close0.63
Mkt Cap (m)51.59
Dividend yield-
ISINUS04545L1070
Volume458,948
Exchange VenueNAS

Company Profile

Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.

Key Information
Price/Earning-
Price/Book0.89
Price/Sales0.20
P/CF0.50
Rev Growth (3 year avg)-20.45
EPS Growth (3 year avg)-
Operating Margin % -0.33
Net Margin %-94.64
Return on Equity-156.10
Debt/Equity6.18

Documents

Prospectus
en 05/09/2014
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)390343456381312230
Operating Income (m)237-2525-464-1
Net Income (m)132-76-89-10237-217
Basic EPS2.26-1.26-1.45-1.630.58-3.07
Avg. Diluted Shares Outstanding (m)666061636471
Balance Sheet
USD201420152016201720182019
Current Assets (m)618309306231208104
Non Current Assets (m)931,054919808725423
Total Assets (m)7111,3631,2251,039933527
Current Liabilities (m)57220227311246185
Total Liabilities (m)------
Total Equity (m)36431525117022058
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-5614466627290
Capital Expenditure (m)-1-27-3-1-6-1
Figures are quoted in USD unless stated otherwise
-
No change
$
0.63
Last Price